ORENF yields 3.81% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ORENF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ORENF + PFE for your $10,000?
Origin Enterprises plc provides agronomy services company in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania, Ukraine, and Latin America. It develops products and services to improve soil fertility, nutrient use efficiency, and crop productivity. The company provides integrated agronomy and on-farm services comprising agronomy advice, services, and inputs directly to arable, fruit, and vegetable growers; and seed, nutrients, crop protection products and digital tools. It also offers procurement and supply chain solutions comprising prescription blended fertilizers and animal feed ingredients; and digital agronomy applications and agri-tech services to primary producers, input manufacturers, and agri-service companies. In addition, the company engages in the provision of advisory, service, and input, as well as turf and amenity management solutions to the professional sports turf, landscaping, and amenity sectors. Further, it is involved in the manufacture and distribution of landscaping, forestry, and maintenance equipment; IT implementation, maintaining, and licensing of software; grain handling; grain and feed trading; property trading; provender milling; and silo operation business. Additionally, the company provides sports and amenities; and agricultural and construction inputs. It provides its solutions under the Agrii, Goulding, Fortgreen, RHIZA, Origin Amenity Solutions, Origin Fertilisers, PB Kent, Linemark, Green-tech, and Origin Digital brand names. Origin Enterprises plc was incorporated in 2006 and is based in Dublin, Ireland.
Full ORENF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.